Venture Capital Updates

Dear Reader,

We have two very important updates on recent venture capital recommendations.

***Koios Beverage Corp.

SALES VELOCITY: One Company’s Hypergrowth Can be Your Opportunity!

***ICC International Cannabis

EUROPEAN CBD MARKET TAKEOVER: First-Mover Status Achieved!

Full Update Below…

KBEVF: The numbers don’t lie, and no one can deny the astonishing growth of Koios Beverage Corp. (CSE: KBEV; OTC: KBEVF), which we suggested to you when it was just a small functional beverage company with a share price of only $0.15 (today, it’s $0.46).

Purchase agreements from the likes of GNC and Walmart changed all of that, and Koios is now changing the functional beverage industry as we know it. The sales trajectory is straight-up vertical, with the company just releasing Q1 2019 sales numbers that outpaced even the most optimistic expectations.

During the first quarter, Koios added an additional 4,000 retail locations that carry its products across the United States. Purchase orders for Koios products from February 1 through March 13 totaled more than CAD$734,876, and that doesn’t even include their online revenues through Amazon and the Koios Website.

The near-term outlook is even better, with management estimating that Koios will add an additional 2,500 retail locations carrying its products across the United States in Q2 of 2019.

While the GNC and Walmart deals are undoubtedly terrific product carriers, much of Koios’ product sales will also take place in Alfalfa’s, Local Grocer, Tony’s Meats, Go Fresh, and other specialty stores across the country.
Koios’ digital reach has also increased substantially, with GNC and Walmart having added Koios to their digital portfolios, thereby allowing consumers to purchase from their e-commerce platforms. As a result, the increase in e-commerce sales of Koios’ products during Q1 of 2019 has been substantial, to say the least.
In a savvy and forward-thinking move, Koios has partnered with Wishing-U-Well, an established Amazon partner, to optimize Koios’ Amazon storefront and approach and keep the company highly competitive. Once the Amazon storefront is launched in May of 2019, customers from all over North America will be able to order any of the company’s products through Amazon Prime.

In tandem with the Amazon storefront push, Koios will be adding a subscription service to its Website that will add greater value to its core customer base and will help generate recurring revenues monthly. The Website will be enhanced and streamlined, allowing for greater volume and revenues, as well as increased efficiencies, margins, customer retention, and attention.

Even though the stock is up 207% since we first recommended it, I consider it a strong buy here for my own personal portfolio, and I have recently added significantly to my own position.

Research and consider adding Koios Beverage Corp. (CAD: KBEV & US: KBEVF) to your investment portfolio.

***Keep in mind that it is still a speculative position due to the stage of its business and market cap valuation still being far from a billion dollars.

93% Of Investors Generate Annual Returns, Which Barely Beat Inflation.

Wealth Education and Investment Principles Are Hidden From Public Database On Purpose!

Build The Knowledge Base To Set Yourself Up For A Wealthy Retirement and Leverage The Relationships We Are Forming With Proven Small-Cap Management Teams To Hit Grand-Slams!

    WLDCF: Every successful cannabis stock investor I’ve spoken to knows that the CBD or cannabidiol market is the future of the industry. Few investors truly appreciate the magnitude of the international market, however: with its massive, untapped consumer base, it’s a cash cow in the making, with far less competition than we’re seeing in North America.

    There’s a trade secret industry insiders would prefer that I not share with you, but I don’t mind risking their ire: the only company with all of the necessary licenses, capital, connections, and distribution networks to truly dominate the international CBD market right now is ICC International Cannabis Corp. (CSE: WRLD.U, US: WLDCF).

    This company has already developed a platform for the cultivation, extraction, formulation, and distribution of CBD and other cannabis products in the United Kingdom, Denmark, Poland, Switzerland, Germany, Greece, Italy, Portugal, and other high-growth regions. Through a series of strategic partnerships, they’ve basically made it impossible for any other CBD company to achieve first-mover status in these regions.

    It’s a brilliant move: while other cannabis companies (and investors, for that matter) are solely focusing on the saturated North American market, ICC has established a firm foothold in a gigantic region with over 700 million people. For ICC, catering to the European consumer base provides a unique opportunity to service a marketplace that’s already familiar with CBD and primed for accelerated growth.
    I mentioned ICC’s strategic partnerships, and their latest one’s a real game-changer: the company just announced that they’re joining with Authentic Brands Group (ABG) to market and distribute popular and established CBD-derived health and wellness products throughout the European Union.
    The world-class product offerings will be comprised of therapeutic balms, CBD-infused cosmetics, and CBD concentrates (isolates and oils), as well as functional supplemental and wellness products tailored to the tastes of the European consumer. The highly recognizable brand names will include Marilyn Monroe, Thalia, Greg Norman, Elvis Presley, Tretorn, Aéropostale, and Frederick’s of Hollywood.
    In addition to ICC’s already massive existing base of 39,000 retail outlets and pharmacies, the ABG partnership provides potential access to tens of thousands of distribution channels and points of sale where the existing offerings can potentially be augmented by CBD products.

    This groundbreaking partnership with ABG creates a true “House of Brands” for ICC that complements its aggressive product strategy by delivering unique CBD-based solutions to diverse, targeted audiences throughout the European Union. From students to senior citizens, and even domestic pets, the combination of ICC’s and ABG’s product lines will leverage brands that are both known and trusted across the entire European potential consumer base.

    In light of this, International Cannabis Corp. CEO Eugene Beukman is eager to work with ABG to make inroads into the highly lucrative European CBD market. As Mr. Beukman explains, “The European marketplace for CBD crosses nearly all demographics and product categories.

    We believe that whether consumers are familiar with CBD or are first-time users, they will gravitate towards these recognizable brand names.”

    With the ABG deal sealed, ICC isn’t just the first choice for international CBD market exposure – they’re the only serious choice, with value-added strategic partnerships designed to propel the company and its stockholders to the next level in the global cannabis trade.

    I recently purchased an additional 1 million shares of the company and see it as one of the most important picks in my portfolio.

    Research and consider adding ICC International Cannabis Corp. (CSE: WRLD.U, US: WLDCF) to your investment portfolio.

    Both of the updates today are in the speculative category in order to make unusually large gains, and maybe even add a comma to our net worth… With that in mind, these are positions that should be small relative to your investible wealth.

    Best Regards,

    Daniel Ameduri

    93% Of Investors Generate Annual Returns, Which Barely Beat Inflation.

    Wealth Education and Investment Principles Are Hidden From Public Database On Purpose!

    Build The Knowledge Base To Set Yourself Up For A Wealthy Retirement and Leverage The Relationships We Are Forming With Proven Small-Cap Management Teams To Hit Grand-Slams!

      Legal Notice: This work is based on SEC filings, current events, interviews, corporate press releases and what we’ve learned as financial journalists. It may contain errors and you shouldn’t make any investment decision based solely on what you read here. It’s your money and your responsibility. The information herein is not intended to be personal legal or investment advice and may not be appropriate or applicable for all readers. If personal advice is needed, the services of a qualified legal, investment or tax professional should be sought.

      Never base any decision off of our emails. stock profiles are intended to be stock ideas, NOT recommendations. The ideas we present are high risk and you can lose your entire investment, we are not stock pickers, market timers, investment advisers, and you should not base any investment decision off our website, emails, videos, or anything we publish.  Please do your own research before investing. It is crucial that you at least look at current SEC filings and read the latest press releases. Information contained in this profile was extracted from current documents filed with the SEC, the company web site and other publicly available sources deemed reliable. Never base any investment decision from information contained in our website or emails or any or our publications. Our report is not intended to be, nor should it be construed as an offer to buy or sell, or a solicitation of an offer to buy or sell securities, or as a recommendation to purchase anything. This publication may provide the addresses or contain hyperlinks to websites; we disclaim any responsibility for the content of any such other websites. We have entered into an agreement for three hundred thousand dollars and five hundred thousand options paid for directly by Koios Beverage Corp. We have also purchased shares and are long the company.  Wallace Hill Partners LTD owned by the same members who own Future Money Trends, have entered into a three year agreement with International Cannabis and have received seven hundred thousand dollars and one million eight hundred thousand shares paid for directly by the company. Please use our site as a place to get ideas. Enjoy our videos and news analysis, but never make an investment decision off of anything we say. Please review our entire disclaimer at